Search Results - "Franjic, Neven"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Transient elastography(Fibro Scan~?) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease- Where do we stand? by Mikolasevic, Ivana, Orlic, Lidija, Franjic, Neven, Hauser, Goran, Stimac, Davor, Milic, Sandra

    Published in World journal of gastroenterology : WJG (28-08-2016)
    “…Non-alcoholic fatty liver disease(NAFLD) is the most common cause of chronic liver disease worldwide. Currently, the routinely used modalities are unable to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Stomach--key player in the regulation of metabolism by Štimac, Davor, Klobučar Majanović, Sanja, Franjić, Neven

    Published in Digestive diseases (Basel) (01-01-2014)
    “…Although the stomach is often perceived as a crude, food-grinding, muscular bag, scientific breakthroughs have shown us that in the case of the stomach there…”
    Get more information
    Journal Article
  4. 4

    Mean platelet volume (MPV) as prognostic factor in acute pancreatitis (AP) by Franjic, Neven, Mikolasevic, Ivan a, Stimac, Davor

    “…According to the literature, only few studies have investigated the association between AP and MPV…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome by Mikolasevic, Ivana, Milic, Sandra, Orlic, Lidija, Stimac, Davor, Franjic, Neven, Targher, Giovanni

    Published in Journal of diabetes and its complications (01-09-2016)
    “…Abstract Background/Aims We examined the relationship between controlled attenuation parameter (CAP) and liver stiffness measurements (LSM), as assessed by…”
    Get full text
    Journal Article
  7. 7

    Place of biologic therapy in the treatment of inflammatory bowel diseases and assessment of its efficacy by Krznarić, Zeljko, Stimac, Davor, Franjić, Neven, Kunović, Ana, Kelecić, Dina Ljubas

    Published in Acta medica Croatica (01-04-2013)
    “…Biological therapy (infliximab and adalimumab) in inflammatory bowel diseases is based on the IgG1 anti-TNF monoclonal antibodies with potent anti-inflammatory…”
    Get full text
    Journal Article
  8. 8

    MJESTO BIOLOŠKE TERAPIJE U LIJEČENJU UPALNIH BOLESTI CRIJEVA I PROCJENA NJENE DJELOTVORNOSTI by KRZNARIĆ, ŽELJKO, ŠTIMAC, DAVOR, FRANJIĆ, NEVEN, KUNOVIĆ, ANA, LJUBAS KELEČIĆ, DINA

    Published in Acta medica Croatica (28-11-2013)
    “…Biološka terapija (infliksimab i adalimumab) u upalnim bolestima crijeva temelji se na IgG1 anti-TNF monoklonalnim antitijelima sa snažnim protuupalnim…”
    Get full text
    Journal Article